What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...

Please provide your email address to receive an email when new articles are posted on . FDA drug approvals have led to significant advancement in endometrial cancer treatment. Stage and histology ...

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

University of Iowa doctoral student Katie Colling is making progress in identifying hormones that are effective at combating ...

The current study looked at treatment data from 2 randomized trials conducted by the Women’s Health Initiative with long term follow up. The effects of MHT on incidence and mortality from ovarian ...

Last week, the US Food and Drug Administration (FDA) made a significant announcement, approving a new therapeutic regimen for patients with endometrial cancer. This malignancy, which develops in the ...

Side effects depend on treatment type, and it’s important to tell your healthcare provider if you notice any. “Patients should be familiar with what signs and symptoms to monitor ‌and feel encouraged ...

Brachytherapy is an internal radiation therapy that people may have during treatment for endometrial cancer. A doctor may suggest brachytherapy after surgery or if surgery is not an option. The ...

Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...

Ramez N. Eskander, MD, discusses the optimal use of lenvatinib/pembrolizumab in clinical practice for patients with ...

Fran Drescher says trauma from a home invasion in her 20s contributed to her uterine cancer diagnosis at 42, urging women not ...

In this retrospective cohort study of a large population in Belgium, researchers aimed to examine endometrial cancer risk in patients with breast cancer who received tamoxifen.